MIP PHARMA DANMARK ApS: Financial statements 2021
CVR: 32886280
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -38,537 and a net result of DKK -52,682 compared with DKK -37,935 the year before. Equity in the 2021 report amounted to DKK -307,785.
- Gross Profit
- DKK -38,537
- Profit/Loss
- DKK -52,682
- Equity
- DKK -307,785
- Total Assets
- DKK 22,007
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -39 t. | -53 t. | -308 t. | - |
| 2020 | - | -24 t. | -38 t. | -255 t. | 0 |
| 2019 | - | -23 t. | -33 t. | -217 t. | 0 |
| 2018 | - | -27 t. | -35 t. | -184 t. | 0 |
| 2017 | - | -34 t. | -39 t. | -149 t. | - |
Official annual report
Find more companies like MIP PHARMA DANMARK ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.